{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:41:36Z","timestamp":1790757696086,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,24]],"date-time":"2019-11-24T00:00:00Z","timestamp":1574553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 NS094595"],"award-info":[{"award-number":["R01 NS094595"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-17-2-0055"],"award-info":[{"award-number":["W81XWH-17-2-0055"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["5T32EY007135"],"award-info":[{"award-number":["5T32EY007135"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30 EY008126"],"award-info":[{"award-number":["P30 EY008126"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY022349"],"award-info":[{"award-number":["R01 EY022349"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.nbd.2019.104695","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T11:35:30Z","timestamp":1574681730000},"page":"104695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Galantamine protects against synaptic, axonal, and vision deficits in experimental neurotrauma"],"prefix":"10.1016","volume":"134","author":[{"given":"Sarah","family":"Naguib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Bernardo-Col\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Cencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Gandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonia S.","family":"Rex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2019.104695_bb0005","doi-asserted-by":"crossref","DOI":"10.5812\/atr.21639","article-title":"A brief overview of ocular trauma","volume":"3","author":"Aghadoost","year":"2014","journal-title":"Arch. Trauma Res."},{"key":"10.1016\/j.nbd.2019.104695_bb0010","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1038\/cddis.2009.23","article-title":"Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors","volume":"1","author":"Almasieh","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2019.104695_bb0015","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1167\/iovs.12-11481","article-title":"Acetylcholinesterase inhibition promotes retinal vasoprotection and increases ocular blood flow in experimental glaucoma","volume":"54","author":"Almasieh","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.nbd.2019.104695_bb0020","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1001\/archopht.119.11.1693","article-title":"The nature, incidence, and impact of eye injuries among US military personnel: implications for prevention","volume":"119","author":"Andreotti","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.nbd.2019.104695_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-1061-4","article-title":"Antioxidants prevent inflammation and preserve the optic projection and visual function in experimental neurotrauma","volume":"9","author":"Bernardo-Colon","year":"2018","journal-title":"Cell Death Dis."},{"issue":"719","key":"10.1016\/j.nbd.2019.104695_bb0030","article-title":"Progression and pathology of traumatic optic neuropathy from repeated primary blast exposure","volume":"13","author":"Bernardo-Col\u00f3n","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2019.104695_bb0035","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/35013070","article-title":"Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin","volume":"405","author":"Borovikova","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2019.104695_bb0040","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1167\/iovs.14-14353","article-title":"Molecular changes and vision loss in a mouse model of closed-globe blast trauma","volume":"55","author":"Bricker-Anthony","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.nbd.2019.104695_bb0045","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4103\/1673-5374.247463","article-title":"Indirect traumatic optic neuropathy: modeling optic nerve injury in the context of closed head trauma","volume":"14","author":"Burke","year":"2019","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.nbd.2019.104695_bb0050","first-page":"47","article-title":"Galantamine: a novel neuroprotective strategy for injured retinal ganglion cells in Glaucoma","author":"Di Polo","year":"2006","journal-title":"Invest. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.nbd.2019.104695_bb0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/neu.2015.4373","article-title":"Glutamate neurotransmission in rodent models of traumatic brain injury","volume":"34","author":"Dorsett","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.nbd.2019.104695_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ph11020044","article-title":"Old drugs as new treatments for neurodegenerative diseases","volume":"11","author":"Dur\u00e3es","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.nbd.2019.104695_bb0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuro.2007.11.004","article-title":"Antioxidative properties of galantamine on neuronal damage induced by hydrogen peroxide in SK-N-SH cells","volume":"29","author":"Ezoulin","year":"2008","journal-title":"Neurotoxicology"},{"issue":"99\u2013106","key":"10.1016\/j.nbd.2019.104695_bb0075","article-title":"Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor","volume":"2","author":"Faghih","year":"2007","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.nbd.2019.104695_bb0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archopht.1989.01070010517021","article-title":"Ocular Trauma Epidemiology","volume":"107","author":"Feist","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.nbd.2019.104695_bb0085","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1017\/S1092852900014164","article-title":"The interplay of neurotransmitters in Alzheimer\u2019s disease","volume":"10","author":"Francis","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.nbd.2019.104695_bb0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijdevneu.2014.06.011","article-title":"Galantamine, an acetylcholinesterase inhibitor, reduces brain damage induced by hypoxia-ischemia in newborn rats","volume":"37","author":"Furukawa","year":"2014","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.nbd.2019.104695_bb0095","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0079-6123(08)62493-0","article-title":"The cholinergic receptor system of the human brain: neurochemical and pharmacological aspects in aging and Alzheimer","volume":"79","author":"Giacobini","year":"1989","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2019.104695_bb0100","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-015-0545-1","article-title":"Glutamate and GABA imbalance following traumatic brain injury","volume":"15","author":"Guerriero","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.nbd.2019.104695_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.exer.2012.03.013","article-title":"A mouse model of ocular blast injury that induces closed globe anterior and posterior pole damage","volume":"99","author":"Hines-Beard","year":"2012","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.nbd.2019.104695_bb0115","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1017\/S1461145714000613","article-title":"Galantamine promotes adult hippocampal neurogenesis via muscarinic and \u03b17 nicotinic receptors in mice","volume":"17","author":"Kita","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2019.104695_bb0120","doi-asserted-by":"crossref","first-page":"031","DOI":"10.1055\/s-0034-1393734","article-title":"Traumatic optic neuropathy: a review","volume":"8","author":"Kumaran","year":"2014","journal-title":"Craniomaxillofac. Trauma Reconstr."},{"key":"10.1016\/j.nbd.2019.104695_bb0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1527-3458.2002.tb00221.x","article-title":"Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer\u2019s disease","volume":"8","author":"Lilienfeld","year":"2002","journal-title":"CNS Drug. Rev."},{"issue":"2","key":"10.1016\/j.nbd.2019.104695_bb0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/brb3.118","article-title":"Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity","volume":"3","author":"Lopes","year":"2013","journal-title":"Brain. Behav."},{"key":"10.1016\/j.nbd.2019.104695_bb0135","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.ajpath.2017.03.005","article-title":"Lasting retinal injury in a mouse model of blast-induced trauma","volume":"187","author":"Mammadova","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2019.104695_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2014.04.003","article-title":"Military-related traumatic brain injury and neurodegeneration","volume":"10","author":"McKee","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2019.104695_bb0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1460-9568.2009.06612.x","article-title":"Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons","volume":"29","author":"Melo","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104695_bb0150","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1017\/S1461145710000222","article-title":"Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1\/2 systems","volume":"13","author":"Noda","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2019.104695_bb0155","first-page":"2020","article-title":"Traumatic brain injury down-regulates glial glutamate transporter (GLT-1 and GLAST) proteins in rat brain","volume":"70","author":"Rao","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.104695_bb0160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-079X.2010.00778.x","article-title":"Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells","volume":"49","author":"Romero","year":"2010","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.nbd.2019.104695_bb0170","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jphs.2015.03.004","article-title":"Interaction between anti-Alzheimer and antipsychotic drugs in modulating extrapyramidal motor disorders in mice","volume":"127","author":"Shimizu","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2019.104695_bb0175","article-title":"Indirect traumatic optic neuropathy","volume":"3","author":"Singman","year":"2016","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.nbd.2019.104695_bb0180","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ajo.2011.02.007","article-title":"Traumatic optic neuropathy: an evolving understanding","volume":"151","author":"Steinsapir","year":"2011","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.nbd.2019.104695_bb0185","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/ejn.14307","article-title":"The overlooked aspect of excitotoxicity: glutamate-independent excitotoxicity in traumatic brain injuries","volume":"49","author":"Tehse","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2019.104695_bb0190","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/sj.bjp.0706221","article-title":"Effect of galantamine on the human \u03b17 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity","volume":"145","author":"Texid\u00f3","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2019.104695_bb0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/WNO.0b013e31821c9b11","article-title":"How should patients with indirect traumatic optic neuropathy be treated?","volume":"31","author":"Volpe","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.nbd.2019.104695_bb0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/ICU.0b013e32833f00c9","article-title":"Traumatic optic neuropathy: a review of the current literature","volume":"21","author":"Warner","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.nbd.2019.104695_bb0200","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/HTR.0b013e3181956ffd","article-title":"Traumatic brain injury associated with combat ocular trauma","volume":"24","author":"Weichel","year":"2009","journal-title":"J. Head Trauma Rehabil."},{"key":"10.1016\/j.nbd.2019.104695_bb0205","series-title":"Priority Eye Diseases","author":"WHO","year":"2018"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119303705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119303705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:34:38Z","timestamp":1777602878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996119303705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":39,"alternative-id":["S0969996119303705"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104695","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galantamine protects against synaptic, axonal, and vision deficits in experimental neurotrauma","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.104695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104695"}}